InnovoTEX
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3800 N Lamar Blvd Ste 200, Austin, Texas...Phone Number
(570) 510-6372Website
www.innovotexinc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About InnovoTEX
INNOVOTEX Inc. is a mid-stage pharmaceutical company focused on developing the TEX Core portfolio of novel therapeutics aimed at treating multiple solid tumor indications. The company is pioneering macrocycle drug conjugates (MDCs) that target aggressive, treatment-resistant tumors through clinically validated delivery systems. Their lead candidate, NOVO-111, has demonstrated promising preclinical results and is progressing towards clinical trials. INNOVOTEX is committed to redefining cancer treatment and expanding its market presence through innovative therapeutic solutions.Explore more
InnovoTEX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InnovoTEX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when InnovoTEX launches new products
InnovoTEX, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if InnovoTEX has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on InnovoTEX recently announced quarterly report
Funding: Get notified immidiatlly once InnovoTEX has new funding data
Click to see if InnovoTEX had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at InnovoTEX
Check out if InnovoTEX is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to InnovoTEX
Compare insights from companies similar to InnovoTEX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InnovoTEX is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
InnovoTEX is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about InnovoTEX.
InnovoTEX Tech Stack
A closer look at the technologies used by InnovoTEX
See more technologies
InnovoTEX News & Media
INNOVOTEX Appoints Dr. Krystle Karoscik as CEO to Advance Macrocycle Drug Conjugate Platform into the Clinic
AUSTIN, TX, UNITED STATES, May 14, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a pharmaceutical company advancing a new class of tumor-selective oncology therapeutics known as Macrocycle Drug Conjugates (MDCs), today announced the appointment of Dr. …INNOVOTEX Appoints Dr. Jonathan Arambula to Executive Chairman in Strategic Transition to Expand Oncology Platform
AUSTIN, TX, UNITED STATES, May 12, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a pharmaceutical company advancing next-generation macrocycle drug conjugates (MDCs) for oncology, today announced the strategic promotion of founder Dr. Jonathan Arambula from …INNOVOTEX Appoints James Hussey as Vice Chairman of the Board to Accelerate Strategic Growth and Clinical Advancement
AUSTIN, TX, UNITED STATES, April 28, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a pre-clinical oncology therapeutics company advancing a novel class of oncology therapeutics based on Macrocycle Drug Conjugates (MDCs), today announced the appointment of …Industry Leader Tarak D. Mody, Ph.D., Joins InnovoTEX Inc. Board of Directors
AUSTIN, Texas, July 17, 2024 /PRNewswire/ -- InnovoTEX Inc., a pre-clinical stage oncology therapeutics company, today announced the appointment of Tarak D. Mody, Ph.D., to its board of directors. InnovoTEX is developing a proprietary platform called TEX Core that produces next-generation...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InnovoTEX
Sign Up For FreeTo access detailed company insights
INNOVOTEX Inc. is a mid-stage pharmaceutical company focused on developing the TEX Core portfolio of novel therapeutics aimed at treating multiple solid tumor indications. The company is pioneering macrocycle drug conjugates (MDCs) that target aggressive, treatment-resistant tumors through clinically validated delivery systems. Their lead candidate... Read More
